STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,120 | -75.7% | 538 | -34.5% | 0.00% | – |
| Q2 2023 | $8,727 | +16.3% | 821 | -8.9% | 0.00% | – |
| Q1 2023 | $7,505 | +65.6% | 901 | +83.5% | 0.00% | – |
| Q4 2022 | $4,532 | -74.8% | 491 | -65.8% | 0.00% | – |
| Q3 2022 | $18,000 | -10.0% | 1,435 | -5.2% | 0.00% | – |
| Q2 2022 | $20,000 | +150.0% | 1,514 | +317.1% | 0.00% | – |
| Q1 2022 | $8,000 | +166.7% | 363 | +200.0% | 0.00% | – |
| Q4 2021 | $3,000 | -85.0% | 121 | -79.8% | 0.00% | – |
| Q3 2020 | $20,000 | +42.9% | 600 | 0.0% | 0.00% | – |
| Q2 2020 | $14,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q1 2020 | $14,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |